industries-serve-min

Sectors Served

MSG Securities covers all sectors on the telecom, media, technology, health care and life sciences industries.

cloudservices

Telecom

consumerelect

Media

consumerinternet

Technology

Health Care

enterprise-software

Enterprise Software

Life Sciences

TMT Practice Area

The TMT sector is a $10 Trillion global industry reshaping today’s societies. It is characterized by substantial growth, change and competition.

While the sector appears to include a wide range of companies, they have important aspects in common, including high levels of innovation and intellectual property, the emergence of non-traditional competitors and business models, and lofty valuations by classic financial metrics.

Unsurprisingly, TMT businesses themselves are converging, driven by digital disruption, stiff competition and the drive for differentiation. These factors generate high demand for capital and acquisitions.

TMT is a primary focus for MSG, and our bankers have decades of experience in the sector. Our client relationships tend to be long-standing, and are supported by our international reach, deep industry knowledge and technical ability to package, structure and close transactions.

Health Care and Life Sciences Practice Area

The various sectors of health care and life sciences are vibrant and marked by continuous productive activity. Global health care expenditures are expected to grow rapidly to over $10 Trillion in 2022. Similarly, the life sciences are blossoming with the rise of digital technologies and the accelerating growth of gene and cell therapies.

In order to provide sophisticated strategic and transactional advice to companies operating at the intersections of technology and health care / life sciences, MSG has partnered with Bernstein Williams & Co., the premier boutique investment bank serving the health care and life sciences industries. BWC’s bankers have relevant, hands-on experience in these industries, including former roles as senior executives, clinical / research professionals, and institutional investors.

Our collective level of expertise in technology and health care / life sciences positions this partnership uniquely to provide business leaders and investors with solutions and opportunities to capitalize on the confluence and rapid evolution of digital technologies, therapeutics, regulation, science, and engineering.

bwco_300